Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

3 Citaten (Scopus)

Toegang tot document

@article{c1dbe476d1714da98aca509ca4b9366c,

title = "Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors",

author = "Leerink, \{Jan M.\} and Feijen, \{Elizabeth A.M.\}",

year = "2024",

month = feb,

doi = "10.1016/S1470-2045(24)00001-9",

language = "English",

volume = "25",

pages = "154--156",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors

AU - Leerink, Jan M.

AU - Feijen, Elizabeth A.M.

PY - 2024/2

Y1 - 2024/2

UR - https://www.scopus.com/pages/publications/85181956448

U2 - 10.1016/S1470-2045(24)00001-9

DO - 10.1016/S1470-2045(24)00001-9

M3 - Comment/debate

C2 - 38215763

AN - SCOPUS:85181956448

SN - 1470-2045

VL - 25

SP - 154

EP - 156

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -